News

Our CEO Sandra Hartbach and Quality Manager Stefanie Fraunschiel were featured as speakers at this year’s TÜV Austria Quality Day – an event filled with the latest news and opportunities for quality professionals to share experiences. Together, they offered insights…

Yesterday was that time of year again: The Golden Scalpels were awarded for the most creative pharma and healthcare campaigns of the past year. For us, this evening is a real highlight every year. Why? ✨ Because we get to…

Once again this year, IGEPHA hosted its Open House industry event — held in a different impressive venue each year. This time, we gathered on the roof terrace of the Radisson Red Hotel, with views over Vienna. 💡 Keynote speakers…

Geopolitical tensions, rising costs, and regulatory requirements are presenting new challenges for the pharmaceutical supply chain. 👉 Our CEO Sandra Hartbach contributed to this year’s CPHI Pharma Trends Outlook Report, highlighting the key areas of tension: While other regions are…

During a presentation by Bernd Schmutterer and Oliver Dvorsky from FPX, we took a look at the topic of ESG — specifically, how companies approach sustainability holistically, from environmental and social considerations to responsible corporate governance. As a service provider…

We support pharmaceutical companies across Pharmacovigilance, Regulatory Affairs, Medical Writing, and Quality Management – managing case processing for multiple MAHs. With TheraLyze, we use one system to handle ICSR data entry for all of them. What we get out of…

After more than a decade of dedicated service, our CEO Sandra Hartbach has handed over leadership of the Regulatory Affairs department. Angéline Wlodarczyk has been our new Head of Regulatory Affairs since the beginning of the year. She has been…

🌿 From concept to market-ready formulation. Do you want to develop your own food supplement — strategically planned from the start, scientifically based, and legally compliant? In collaboration with Dr. Christian Egger, an expert in the development, regulatory affairs, and…

The targeted identification, engagement, and support of patients is now a key success factor for pharmaceutical companies — especially in the field of rare diseases. Together with Insight Health, we offer a new modular service portfolio that supports pharmaceutical companies…

We were delighted to be part of IGEPHA’s Come Together event again this year – a strong start to the year for the pharmaceutical and healthcare industry. 💡 The evening focused on the question of how to sustainably relieve the…